WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Thursday reported a loss of $55.3 million in its third quarter.
On a per-share basis, the Wayne, Pennsylvania-based company said it had a loss of $1.34. Losses, adjusted to account for discontinued operations, were 56 cents per share.
The specialty pharmaceutical company posted revenue of $983,000 in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $5.9 million.
In the final minutes of trading on Thursday, the company's shares hit $1.69. A year ago, they were trading at $12.02.